Loading...

ENDRA Life Sciences Inc.

NDRA•NASDAQ
Healthcare
Medical - Diagnostics & Research
$5.82
$-0.53(-8.35%)

ENDRA Life Sciences Inc. (NDRA) AI-Powered Stock Analysis

See how ENDRA Life Sciences Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

ENDRA Life Sciences Inc. (NDRA) Stock Overall Grade

ENDRA Life Sciences Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

C+

Normal

Grade Breakdown by Metric

See how each financial and market factor contributes to ENDRA Life Sciences Inc.'s overall stock rating.

Forecast

C

Score

45/100

Financial Growth

C

Score

40/100

Fundamental Growth

C

Score

41/100

Key Ratios

C+

Score

55/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B

Score

65/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

ENDRA Life Sciences Inc. (NDRA) AI-Powered Stock Analysis

This asset demonstrates Normal performance with an overall Forecast Score of 45/100 (C), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (41/100, C) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.

Component Analysis Explained

Understand the key factors behind each ENDRA Life Sciences Inc. stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

;